Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA STRIDES PHARMA SCIENCE AJANTA PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 38.3 -1,455.3 - View Chart
P/BV x 8.3 3.3 253.6% View Chart
Dividend Yield % 0.3 0.2 163.2%  

Financials

 AJANTA PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
AJANTA PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs1,426392 363.5%   
Low Rs1,062263 403.2%   
Sales per share (Unadj.) Rs297.2408.5 72.8%  
Earnings per share (Unadj.) Rs46.7-25.6 -182.6%  
Cash flow per share (Unadj.) Rs57.11.4 4,173.0%  
Dividends per share (Unadj.) Rs7.001.50 466.7%  
Avg Dividend yield %0.60.5 123.0%  
Book value per share (Unadj.) Rs269.1242.8 110.8%  
Shares outstanding (eoy) m125.9190.30 139.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.20.8 521.4%   
Avg P/E ratio x26.6-12.8 -207.8%  
P/CF ratio (eoy) x21.8239.6 9.1%  
Price / Book Value ratio x4.61.4 342.5%  
Dividend payout %15.0-5.9 -255.5%   
Avg Mkt Cap Rs m156,63829,603 529.1%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8517,320 107.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42636,884 101.5%  
Other income Rs m9861,352 72.9%   
Total revenues Rs m38,41338,236 100.5%   
Gross profit Rs m7,833830 943.9%  
Depreciation Rs m1,3082,433 53.8%   
Interest Rs m582,611 2.2%   
Profit before tax Rs m7,453-2,862 -260.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573-553 -284.4%   
Profit after tax Rs m5,880-2,309 -254.6%  
Gross profit margin %20.92.2 930.2%  
Effective tax rate %21.119.3 109.2%   
Net profit margin %15.7-6.3 -251.0%  
BALANCE SHEET DATA
Current assets Rs m28,25231,353 90.1%   
Current liabilities Rs m11,39329,902 38.1%   
Net working cap to sales %45.03.9 1,145.4%  
Current ratio x2.51.0 236.5%  
Inventory Days Days6671 92.5%  
Debtors Days Days10129 8.0%  
Net fixed assets Rs m18,70731,300 59.8%   
Share capital Rs m253903 28.0%   
"Free" reserves Rs m33,62421,025 159.9%   
Net worth Rs m33,87721,928 154.5%   
Long term debt Rs m1311,398 0.1%   
Total assets Rs m47,04763,734 73.8%  
Interest coverage x128.6-0.1 -134,032.3%   
Debt to equity ratio x00.5 0.1%  
Sales to assets ratio x0.80.6 137.5%   
Return on assets %12.60.5 2,659.9%  
Return on equity %17.4-10.5 -164.8%  
Return on capital %22.2-0.8 -2,947.6%  
Exports to sales %59.946.7 128.4%   
Imports to sales %11.50-   
Exports (fob) Rs m22,42017,213 130.2%   
Imports (cif) Rs m4,293NA-   
Fx inflow Rs m22,42018,113 123.8%   
Fx outflow Rs m4,293672 639.3%   
Net fx Rs m18,12717,442 103.9%   
CASH FLOW
From Operations Rs m7,918444 1,782.8%  
From Investments Rs m-5,5963,025 -185.0%  
From Financial Activity Rs m-1,079-2,139 50.4%  
Net Cashflow Rs m1,2431,328 93.6%  

Share Holding

Indian Promoters % 66.2 27.4 241.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 38.9 66.3%  
FIIs % 9.1 19.5 46.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 72.6 46.5%  
Shareholders   54,351 91,182 59.6%  
Pledged promoter(s) holding % 12.3 69.2 17.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs STRIDES PHARMA SCIENCE Share Price Performance

Period AJANTA PHARMA STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 2.51% 1.16% 1.18%
1-Month 7.60% 0.35% -0.75%
1-Year 92.91% 176.88% 61.82%
3-Year CAGR 21.63% -3.35% 18.16%
5-Year CAGR 26.85% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.